Information:
Error:
ID
34149
Description
PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00816582
Link
https://clinicaltrials.gov/show/NCT00816582
Keywords
Versions (1)
- 1/14/19 1/14/19 -
Copyright Holder
GSK group of companies
Uploaded on
January 14, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00816582
Eligibility Breast Cancer NCT00816582
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00816582
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
post-menopausal (≥ 60 years old, or age ≥ 45 years with amenorrhea for > 12 months or follicle stimulating hormone and estrogen levels within post-menopausal range, or prior bilateral oophorectomy)
boolean
ID.2
Item
hormone receptor positive (er and/or pgr) disease as determined locally
boolean
ID.3
Item
who performance status 0-2
boolean
ID.4
Item
life expectancy of ≥ 3 months
boolean
ID.5
Item
the presence of at least one measurable or evaluable (non-measurable) lesion
boolean
ID.6
Item
informed consent prior to any study procedures
boolean
ID.7
Item
life threatening metastatic visceral disease
boolean
ID.8
Item
brain or leptomeningeal metastases
boolean
ID.9
Item
prior exposure to fulvestrant
boolean
ID.10
Item
history of bleeding diathesis or need for long term anti-coagulation
boolean